News
AstraZeneca PLC released its flu vaccine nasal spray for at-home use on Friday, an option that comes at a contentious time ...
1h
Inquirer Business on MSNDTI, AstraZeneca to develop Pharma Innovation Hub
The government is partnering with the local subsidiary of multinational pharmaceutical company AstraZeneca to develop the ...
AstraZeneca (LSE:AZN) recently launched "FluMist Home," an at-home flu vaccine delivery service, marking an important ...
The Department of Trade and Industry, through the Philippine Economic Zone Authority (PEZA), sealed a partnership with ...
Starting Friday, Americans can order the nasal spray flu vaccine online and have it shipped directly to their home.
AstraZeneca PLC closed 12.32% short of its 52-week high of £133.88, which the company achieved on September 3rd.
AstraZeneca has issued its flu vaccine nasal spray for at-home use. The nasal spray is authorized for use by adults ages 18-49 and for caregiver use with children ages 2-17, according to an Aug. 15 ...
The treatment is one for those suffering with lung cancer who never smoked, a group of patients who account for up to 25% of ...
AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...
The Department of Trade and Industry (DTI), through the Philippine Economic Zone Authority (PEZA), has teamed up with ...
FluMist has been approved since 2003, but—until last year—only for administration by a healthcare practitioner. The new nod ...
The Philippine Economic Zone Authority (Peza) has sealed a deal with AstraZeneca Pharmaceuticals (Phils.) to establish the country’s first pharma innovation hub, a flagship project aimed at boosting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results